stockrowMedline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
Follow MDLN
Alert me
Medline Inc. (MDLN) Return on assets
Medline Inc.'s return on assets over the twelve months to 30 September 2026 was 1.49%, down 1.6 percentage points from fiscal 2025 (3.11%). That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 3.11% | (3.56) |
| FY2024 | 6.67% | 6.67 |
| FY2023 | 0.00% | — |
Return on assets against peers
| Company | Return on assets |
|---|---|
| RMD ResMed Inc. compare | 19.3% |
| WST West Pharmaceutical Services, Inc. compare | 15.7% |
| ISRG Intuitive Surgical, Inc. compare | 15.3% |
| COO The Cooper Companies, Inc. compare | 4.55% |
| ALC Alcon compare | 2.06% |
| BDX Becton, Dickinson and Company compare | 1.78% |
| MDLN Medline Inc. | 1.49% |
| SOLV Solventum Corporation compare | 1.11% |
| BAX Baxter International Inc. compare | −3.57% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on MDLN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Book value per share
- The full statement